NCT00199368View on ClinicalTrials.gov

An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018

PHASE3CompletedINTERVENTIONAL
Enrollment

1,100

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

March 31, 2007

Study Completion Date

May 31, 2007

Conditions
Parkinson's Disease
Interventions
DRUG

Istradefylline ( KW-6002)

Trial Locations (1)

08540

Kyowa Pharmaceutical Inc., Princeton

Sponsors

Lead Sponsor

Kyowa Kirin, Inc.
All Listed Sponsors
collaborator

Kyowa Hakko Kirin UK, Ltd.

INDUSTRY

lead

Kyowa Kirin, Inc.

INDUSTRY